API

Supriya Lifescience ramps up capacity and global readiness for next phase of growth

Read more

Separate license regime for bulk drugs, API and KSMs, under govt’s consideration

Read more

HRV Pharma and MetroChem forge strategic CDMO alliance 

Read more

Lilly to build $6.5 billion API manufacturing facility in Texas

Read more

Aparna Pharmaceuticals secures EUGMP certification for Pydibhimavaram facility

Read more

Lilly partners with API to launch a CME for obesity

Read more

Alembic Pharmaceuticals receives USFDA EIR for API-III facility in Gujarat

Read more

Supriya Lifescience expands solar power capacity with 5 MWp facility in Maharashtra

Read more

Lupin receives “A-” leadership rating from CDP for climate change and water security

Read more

Axplora invests €50 million in Mourenx Site to expand API and biologics manufacturing

Read more